Integrative study of pulmonary microbiome, transcriptome and clinical outcomes in Mycoplasma pneumoniae pneumonia
- PMID: 38238712
- PMCID: PMC10795342
- DOI: 10.1186/s12931-024-02687-4
Integrative study of pulmonary microbiome, transcriptome and clinical outcomes in Mycoplasma pneumoniae pneumonia
Abstract
Background: This study aimed to investigate the interactions among three core elements of respiratory infection-pathogen, lung microbiome, and host response-and their avocation with the severity and outcomes of Mycoplasma pneumoniae pneumonia (MPP) in children.
Methods: We prospectively collected bronchoalveolar lavage fluid from a cohort of 41 children with MPP, including general MPP (GMPP) and complicated MPP (CMPP), followed by microbiome and transcriptomic analyses to characterize the association among pathogen, lung microbiome, and host response and correlate it with the clinical features and outcomes.
Results: The lung microbiome of patients with CMPP had an increased relative abundance of Mycoplasma pneumoniae (MP) and reduced alpha diversity, with 76 differentially expressed species. Host gene analysis revealed a key module associated with neutrophil function and several inflammatory response pathways. Patients with a high relative abundance of MP, manifested by a specific lung microbiome and host response type, were more prone to CMPP and had a long imaging recovery time.
Conclusion: Patients with CMPP have a more disrupted lung microbiome than those with GMPP. MP, lung microbiome, and host response interacts with each other and are closely related to disease severity and outcomes in children with MPP.
Keywords: Host response; Microbiome; Mycoplasma pneumoniae; Neutrophils; Outcomes.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures






Similar articles
-
Immune response plays a role in Mycoplasma pneumoniae pneumonia.Front Immunol. 2023 May 26;14:1189647. doi: 10.3389/fimmu.2023.1189647. eCollection 2023. Front Immunol. 2023. PMID: 37304280 Free PMC article.
-
BALF editome profiling reveals A-to-I RNA editing associated with severity and complications of Mycoplasma pneumoniae pneumonia in children.mSphere. 2025 Mar 25;10(3):e0101224. doi: 10.1128/msphere.01012-24. Epub 2025 Feb 25. mSphere. 2025. PMID: 39998235 Free PMC article.
-
High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia.BMC Infect Dis. 2019 Dec 10;19(1):1045. doi: 10.1186/s12879-019-4667-y. BMC Infect Dis. 2019. PMID: 31823740 Free PMC article.
-
Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children.J Microbiol Immunol Infect. 2021 Aug;54(4):557-565. doi: 10.1016/j.jmii.2020.10.002. Epub 2020 Oct 17. J Microbiol Immunol Infect. 2021. PMID: 33268306 Review.
-
Enhanced insights into the neutrophil-driven immune mechanisms during Mycoplasma pneumoniae infection.Heliyon. 2024 Oct 4;10(21):e38950. doi: 10.1016/j.heliyon.2024.e38950. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39524902 Free PMC article. Review.
Cited by
-
Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair.Int J Mol Sci. 2024 Apr 5;25(7):4051. doi: 10.3390/ijms25074051. Int J Mol Sci. 2024. PMID: 38612860 Free PMC article. Review.
-
Neutrophils are involved in the development and outcomes of plastic bronchitis associated with Mycoplasma pneumoniae pneumonia.Respir Res. 2025 Mar 8;26(1):92. doi: 10.1186/s12931-025-03167-z. Respir Res. 2025. PMID: 40057734 Free PMC article.
References
-
- Yang TI, Chang TH, Lu CY, Chen JM, Lee PI, Huang LM, et al. Mycoplasma pneumoniae in pediatric patients: do macrolide-resistance and/or delayed treatment matter? J Microbiol Immunol Infect. 2019;52(2):329–35. - PubMed
-
- de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. Lancet. 2020;396(10253):786–98. - PubMed
MeSH terms
Substances
Grants and funding
- 82200008/the Youth Program of National Natural Science Foundation of China
- YKK22162/Nanjing Health Bureau Medical Science and Technology Development Foundation
- BE2019607/Grants from Jiangsu Province Special Funds for Key Program (Social Development)
- 82270008/the General Program of National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources